In recent trading session, Clearside Biomedical Inc (NASDAQ:CLSD) saw 1.86 million shares changing hands at last check today with its beta currently measuring 2.12. Company’s recent per share price level of $0.52 trading at -$0.32 or -38.19% at last check today assigns it a market valuation of $40.15M. That most recent trading price of CLSD’s stock is at a discount of -217.31% from its 52-week high price of $1.65 and is indicating a discount of -34.62% from its 52-week low price of $0.70. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.15 million shares which gives us an average trading volume of 234.03K if we extend that period to 3-months.
For Clearside Biomedical Inc (CLSD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Clearside Biomedical Inc (NASDAQ:CLSD) trade information
Upright in the red during last session for losing -38.19%, in the last five days CLSD remained trading in the red while hitting it’s week-highest on Friday, 07/11/25 when the stock touched $0.52 price level, adding 41.57% to its value on the day. Clearside Biomedical Inc’s shares saw a change of -58.33% in year-to-date performance and have moved -40.98% in past 5-day. Clearside Biomedical Inc (NASDAQ:CLSD) showed a performance of -35.13% in past 30-days. Number of shares sold short was 0.35 million shares which calculate 0.92 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 10.40% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 13.37% while estimates for its earnings growth in next 5 years are of -2.08%.
Clearside Biomedical Inc (NASDAQ:CLSD)’s Major holders
Insiders are in possession of 13.02% of company’s total shares while institution are holding 14.32 percent of that, with stock having share float percentage of 16.46%. Investors also watch the number of corporate investors in a company very closely, which is 14.32% institutions for Clearside Biomedical Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at CLSD for having 2.84 million shares of worth $3.69 million. And as of 2024-06-30, it was holding 3.8003 of the company’s outstanding shares.
The second largest institutional holder is ROSALIND ADVISORS, INC., which was holding about 2.59 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.4692 of outstanding shares, having a total worth of $3.37 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 1.97 shares of worth $1.06 million or 2.54% of the total outstanding shares. The later fund manager was in possession of 783.85 shares on Mar 31, 2025 , making its stake of worth around $0.42 million in the company or a holder of 1.01% of company’s stock.
